Meyka AI API is live for developers.Start building.
Advertisement
Johnson & Johnson

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

JNJNYSE
HealthcareDrug Manufacturers - General
$232.77
$4.60(2.02%)
U.S. Market opens in 46h 50m
Advertisement

Johnson & Johnson (JNJ)

Meyka AI Score

Z

Key Financials

Market Cap560.3B
P/E Ratio27.07
EPS (TTM)$8.63
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$227.93
3 Months$258.08
1 Year Target$179.28

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.07 and a market capitalization of 560.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.01%
5-Day Change
0.66%
1-Month Change
3.18%
3-Month Change
-2.86%
6-Month Change
15.27%
Year-to-Date (YTD) Change
12.47%
1-Year Change
51.48%
3-Year Change
47.02%
5-Year Change
41.21%
All-Time (Max) Change
18979.10%

Contact Information

732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

138,100 Employees
IPO DateJan 2, 1943
CountryUS
Actively Trading

Frequently Asked Questions